newsfilter
← Latest News
GlobeNewswire·

Moleculin Biotech Secures Strategic Additional Patent, Strengthening Global Positioning of Annamycin

Solid Intellectual Property Protection Across Four Continents Ahead of Pending Phase 3 Data Release HOUSTON, May 08, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (NASDAQ:MBRX) ("Moleculin" or the "Company"),